…n funded so far under CIRM’s Strategic Partnership Awards initiative. A grant of $10.1 million was awarded to ViaCyte Inc. to continue preclinical research and initiate clinical testing of an embryonic stem cell-based therapy for patients w...
Through its Common Fund the NIH has established the Center for Regenerative Medicine (NIH CRM), to s
IMAGES-002-HOUSE_OVERSIGHT_013483.txt
p.1
View source release ↗